RCSB MAXIT report on stereochemistry of submitted models,,,,,,,,
,,,,,,,,
PZ17,,,,,,,,
,,,,,,,,
No.,3D RNA model,(a)Close contact,(b)RMSD bond,(c)RMSD angle,(d)Planes,(e)Chiral,(f)Polymer Linkage,Total
1,17_Adamiak_1,0,0,0,0,0,0,0
2,17_Adamiak_2,0,0,0,0,0,0,0
3,17_Adamiak_3,0,0,0,0,0,0,0
4,17_Das_10,0,0,0,0,0,0,0
5,17_Das_4,0,0,0,0,0,0,0
6,17_Das_5,0,0,0,0,0,0,0
7,17_Das_6,0,0,0,0,0,0,0
8,17_Das_7,0,0,0,0,0,0,0
9,17_Das_8,0,0,0,0,0,0,0
10,17_Das_9,0,0,0,0,0,0,0
11,17_DasExtraInfo_1,0,0,0,0,0,0,0
12,17_RNAComposer_AS1_1,0,0,0,0,0,0,0
13,17_RNAComposer_AS1_10,0,0,0,0,0,0,0
14,17_RNAComposer_AS1_2,0,0,0,0,0,0,0
15,17_RNAComposer_AS1_3,0,0,0,0,0,0,0
16,17_RNAComposer_AS1_4,0,0,0,0,0,0,0
17,17_RNAComposer_AS1_5,0,0,0,0,0,0,0
18,17_RNAComposer_AS1_6,0,0,0,0,0,0,0
19,17_RNAComposer_AS1_8,0,0,0,0,0,0,0
20,17_RNAComposer_AS1_9,0,0,0,0,0,0,0
21,17_RNAComposer_AS2_5,0,0,0,0,0,0,0
22,17_RNAComposer_AS2_7,0,0,0,0,0,0,0
23,17_RNAComposer_AS2_8,0,0,0,0,0,0,0
24,17_Das_2,1,0,0,0,0,0,1
25,17_Das_3,1,0,0,0,0,0,1
26,17_RNAComposer_AS2_10,1,0,0,0,0,0,1
27,17_RNAComposer_AS2_2,1,0,0,0,0,0,1
28,17_RNAComposer_AS2_6,1,0,0,0,0,0,1
29,17_RNAComposer_AS2_9,1,0,0,0,0,0,1
30,17_solution_2,0,0,2,0,0,0,2
31,17_RNAComposer_AS1_7,2,0,0,0,0,0,2
32,17_RNAComposer_AS2_1,2,0,0,0,0,0,2
33,17_RNAComposer_AS2_4,2,0,0,0,0,0,2
34,17_Das_1,0,1,2,0,0,0,3
35,17_DasExtraInfo_3,0,1,1,0,0,1,3
36,17_solution_1,2,0,1,0,0,0,3
37,17_DasExtraInfo_2,0,1,5,0,1,1,8
38,17_solution_0,0,0,10,0,0,0,10
39,17_Chen_10,0,0,20,3,1,0,24
40,17_Chen_3,0,0,38,13,2,0,53
41,17_Ding_2,0,0,36,24,0,0,60
42,17_Ding_4,0,0,42,22,0,0,64
43,17_Ding_8,0,1,43,22,0,0,66
44,17_Ding_1,0,0,47,20,0,0,67
45,17_Bujnicki_4,0,0,59,8,1,0,68
46,17_Ding_5,0,0,42,26,0,0,68
47,17_Ding_3,0,0,49,21,0,0,70
48,17_Ding_10,0,0,47,25,0,0,72
49,17_Bujnicki_6,0,0,62,13,0,0,75
50,17_Ding_6,0,0,54,22,0,0,76
51,17_Bujnicki_10,0,0,64,16,1,0,81
52,17_Bujnicki_2,0,0,64,16,1,0,81
53,17_Bujnicki_3,0,0,60,20,1,0,81
54,17_Bujnicki_8,0,17,65,1,0,0,83
55,17_Major_2,0,0,66,17,0,0,83
56,17_Ding_9,0,0,58,27,0,0,85
57,17_Ding_7,0,0,72,19,0,0,91
58,17_Bujnicki_7,0,15,73,4,0,0,92
59,17_Major_3,0,0,72,19,3,0,94
60,17_Major_1,0,0,69,26,0,0,95
61,17_Major_4,0,0,81,17,0,0,98
62,17_Major_6,0,0,74,22,5,0,101
63,17_Major_8,0,0,73,28,4,0,105
64,17_Major_5,0,0,82,24,0,0,106
65,17_Chen_7,0,20,69,22,3,0,114
66,17_Major_7,0,0,93,25,4,0,122
67,17_Dohkolyan_1,0,3,71,50,0,0,124
68,17_Chen_8,0,28,76,18,3,0,125
69,17_Dohkolyan_2,2,2,74,51,0,0,129
70,17_Major_9,4,8,94,15,10,0,131
71,17_Dohkolyan_3,0,1,78,53,0,0,132
72,17_Major_10,4,7,112,28,5,0,156
73,17_Bujnicki_1,0,19,119,16,5,0,159
74,17_Bujnicki_9,0,19,119,16,5,0,159
75,17_Xiao_4,0,0,108,24,32,0,164
76,17_Xiao_2,0,0,105,29,36,0,170
77,17_Xiao_3,0,0,103,34,40,0,177
78,17_Xiao_10,0,0,98,34,47,0,179
79,17_Xiao_1,0,10,121,31,20,0,182
80,17_Xiao_7,0,0,112,39,31,0,182
81,17_SimRNAAS2_2,5,42,107,12,1,17,184
82,17_SimRNAAS1_2,19,42,97,14,0,13,185
83,17_SimRNAAS1_7,6,46,101,22,0,18,193
84,17_Bujnicki_5,0,24,149,17,6,0,196
85,17_SimRNAAS1_8,19,32,118,16,1,11,197
86,17_SimRNAAS2_4,7,49,118,14,1,14,203
87,17_SimRNAAS2_8,18,40,105,20,1,23,207
88,17_SimRNAAS2_3,19,51,113,15,1,14,213
89,17_Xiao_5,4,20,140,27,23,0,214
90,17_SimRNAAS1_1,35,41,113,10,1,19,219
91,17_SimRNAAS1_6,18,50,112,19,1,19,219
92,17_SimRNAAS1_3,25,46,118,17,1,15,222
93,17_SimRNAAS1_9,12,45,126,20,0,19,222
94,17_Chen_9,36,32,127,5,0,23,223
95,17_SimRNAAS2_5,11,49,122,21,2,21,226
96,17_SimRNAAS2_1,28,49,123,15,1,12,228
97,17_SimRNAAS2_7,20,45,125,19,0,19,228
98,17_Chen_2,34,39,133,1,0,23,230
99,17_Xiao_8,4,13,142,32,40,0,231
100,17_Xiao_9,0,11,144,41,39,0,235
101,17_Xiao_6,1,22,153,36,25,0,237
102,17_SimRNAAS2_9,33,50,127,15,2,18,245
103,17_Chen_1,53,33,147,0,0,15,248
104,17_SimRNAAS2_6,15,51,145,24,2,14,251
105,17_SimRNAAS1_5,47,46,122,16,0,22,253
106,17_SimRNAAS1_4,40,49,142,19,0,21,271
107,17_Chen_4,65,41,149,3,0,22,280
108,17_Chen_6,91,40,135,2,0,23,291
109,17_Chen_5,110,31,143,3,1,26,314
110,17_RNAComposer_AS2_3,5,146,146,34,0,0,331
(a) number of identified too-close contacts between symmetry-related molecules in the case of crystallographic experiments.
(b) and (c) RMSD bond and angle lengths.
(d) number of unexpected deviations from planes centers.
(e) number of identified chirality errors.
(f) number of identified polymer linkage artifacts.
Gore, S., García, E. S., Hendrickx, P. M., Gutmanas, A., Westbrook, J. D., Yang, H., ... & Ikegawa, Y. (2017). Validation of structures in the Protein Data Bank. Structure, 25(12), 1916-1927. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718880/